Cheryl Cohen - NantKwest Director
Director
Ms. Cheryl L. Cohen is Director of the Company. She has served as president of CLC Consulting, a pharmaceutical and biotechnology consulting firm specializing in new product startup and commercialization, since 2008. Prior to CLC, Ms. Cohen served as chief commercial officer of Medivation, Inc., a publiclytraded biopharmaceutical company, from September 2011 until July 2014. From November 2007 to September 2008, she served as the vice president, strategic commercial group, of Health Care Systems, Inc., a Johnson Johnson company, and from October 1998 to November 2007, she worked at Janssen Biotech, Inc., a Johnson Johnson company, in a variety of senior sales roles including vice president, rheumatology franchise. Ms. Cohen has served on the board of Aerpio Pharmaceuticals, Inc., a pharmaceutical company, since 2018. Ms. Cohen also served on the board of Vital Therapies, Inc., a therapeutics company, from 2015 until 2019. Since 2015, Ms. Cohen has served on the board of Novus Therapeutics, Inc., a publiclytraded pharmaceutical company focused on the acquisition, development, and commercialization of ear, nose, and throat products. Ms. Cohen served on the board of Protein Sciences Corporationrationration, a privately held biopharmaceutical company specializing in vaccine development from October 2014 to August 2017, and she served on the board of Cytrx Corporationrationration, a publicly traded biopharmaceutical company specializing in oncology, from June 2015 through October 2016. Ms. Cohen began her career at Solvay Pharmaceuticals in a variety of sales positions since 2019.
| Age | 52 |
| Tenure | 5 years |
| Phone | 858 633-0300 |
| Web | www.nantkwest.com |
NantKwest Management Efficiency
The company has Return on Asset (ROA) of (38.83) % which means that for every 100 dollars spent on asset, it generated a loss of $38.83. This is way below average. Likewise, it shows a return on total equity (ROE) of (77.61) %, which implies that it produced no returns to current stockholders. NantKwest's management efficiency ratios could be used to measure how well NantKwest manages its routine affairs as well as how well it operates its assets and liabilities.The company reports 15.31 M of total liabilities with total debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from financial leverage. NantKwest has a current ratio of 3.0, indicating that it is in good position to pay out its debt commitments in time. Debt can assist NantKwest until it has trouble settling it off, either with new capital or with free cash flow. So, NantKwest's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NantKwest sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NantKwest to invest in growth at high rates of return. When we think about NantKwest's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sheryl Sculley | MGIC Investment Corp | 68 | |
| Lawrence Jackson | Assurant | 67 | |
| Kevin Bradicich | The Hanover Insurance | 63 | |
| Ashok Gupta | Sun Life Financial | 56 | |
| Donald Nolan | Apogee Enterprises | 56 | |
| John Clappison | Sun Life Financial | 68 | |
| Harriet Edelman | Assurant | 65 | |
| Barbara Stymiest | Sun Life Financial | 64 | |
| David Weiss | Apogee Enterprises | 71 | |
| Daniel Arrigoni | MGIC Investment Corp | 70 | |
| Robert Marzec | Apogee Enterprises | 71 | |
| Herbert Parker | Apogee Enterprises | 60 | |
| Jerome Davis | Apogee Enterprises | 62 | |
| Greig Woodring | Sun Life Financial | N/A | |
| Richard Reynolds | Apogee Enterprises | 69 | |
| Chuck Chaplin | MGIC Investment Corp | 63 | |
| Joseph Ramrath | The Hanover Insurance | 64 | |
| Cassandra Carr | MGIC Investment Corp | 73 | |
| Scott Powers | Sun Life Financial | 61 | |
| James Ritchie | Kinsale Capital Group | 65 | |
| Krystyna Hoeg | Sun Life Financial | 64 | |
Management Performance
| Return On Equity | -77.61 | |||
| Return On Asset | -38.83 |
NantKwest Leadership Team
Elected by the shareholders, the NantKwest's board of directors comprises two types of representatives: NantKwest inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NantKwest. The board's role is to monitor NantKwest's management team and ensure that shareholders' interests are well served. NantKwest's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NantKwest's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheryl Cohen, Director | ||
| Richard Kusserow, Independent Director | ||
| Angela Wilson, CFO | ||
| Sonja Nelson, Chief Accounting Officer | ||
| Barry Simon, President CEO, Board Member | ||
| Michael Blaszyk, Independent Director | ||
| Frederick Driscoll, Independent Director | ||
| John Thomas, Independent Director | ||
| Robert Rosen, Director | ||
| Richard Tajak, Interim CFO | ||
| Patrick SoonShiong, Chairman of the Board, CEO | ||
| Henry Ji, Director | ||
| John Potts, Independent Director | ||
| Steven Gorlin, Vice Chairman of the Board |
NantKwest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NantKwest a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -77.61 | |||
| Return On Asset | -38.83 | |||
| Current Valuation | 2.76 B | |||
| Shares Outstanding | 108.88 M | |||
| Shares Owned By Insiders | 67.98 % | |||
| Shares Owned By Institutions | 9.78 % | |||
| Number Of Shares Shorted | 5.43 M | |||
| Price To Earning | (3.44) X | |||
| Price To Book | 19.58 X | |||
| Revenue | 111 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in NantKwest Stock
If you are still planning to invest in NantKwest check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NantKwest's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |